| Date | Form | Description | Docs | XBRL | Pages |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 01/28/22 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/13/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/12/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
Read More...Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...